SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing a massive surge in investor interest and volatility following a stronger-than-expected earnings report that highlights accelerating data center and AI-driven CPU demand. While bulls are celebrating a potential multi-decade technical breakout and forced institutional re-rating, the community is actively debating whether current valuation levels are justified given the company's underlying GAAP losses or if this momentum is merely a short-term squeeze fueled by retail FOMO.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is facing significant volatility as investors debate the impact of major enterprise partnerships against concerns over aggressive capital expenditure and ongoing insider selling. The community remains deeply divided, with many bullish on the stock's long-term potential within the AI infrastructure buildout while others express caution over debt-funded expansion.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD shares are surging to all-time highs as investors interpret strong CPU demand from competitors' earnings as a bullish signal for the entire sector's AI infrastructure. The community is deeply divided between long-term holders celebrating a sustained growth story and skeptical traders warning of a blow-off top driven by extreme overbought conditions and potential FOMO.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant volatility as investors digest the strategic acquisition of LivePerson, a move aimed at expanding the company's enterprise customer base and omnichannel capabilities. While the community remains divided between those betting on a potential short squeeze fueled by rising borrow rates and high short interest, others are focused on the long-term potential of the company's voice AI technology.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a significant surge in investor attention fueled by speculation surrounding its role in the AI infrastructure supply chain, specifically through its optical interposer technology and confirmed purchase orders linked to key industry players. The community is actively debating the stock's potential as a long-term play versus a short-squeeze opportunity, with many retail investors expressing high conviction despite notable volatility and a vocal contingent of bears betting against its rapid valuation expansion.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is facing significant bearish sentiment and community frustration due to its continued underperformance relative to the broader market and a perceived lack of aggressive capital deployment. Shareholders are actively debating the company's future under CEO Greg Abel, with many criticizing the heavy cash position and calling for bolder investment strategies or increased share buybacks.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is seeing intense community discussion driven by anticipation of potential licensing deals in the high-performance AI semiconductor sector, with investors closely watching the company's collaboration with tool partners and its integration efforts in 2nm node transistors. While bulls point to technical validation and potential commercial partnerships to justify the stock's recent volatility, others remain cautious due to the company's history of being pre-revenue and past delays in securing definitive commercial agreements.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently attracting intense community attention as traders debate its role in the broader AI infrastructure buildout and its position relative to other surging semiconductor peers. While sentiment remains divided between those expecting a massive breakout fueled by data center demand and those wary of volatility and intense option-based manipulation, the primary focus is on whether the stock will finally shed its consolidation phase to join the recent rally of the broader AI tech sector.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is surging as investors pivot toward energy stocks to support the intensifying power demands of AI data centers, fueled by a new strategic partnership with Nvidia and Los Alamos National Laboratory. The community is actively discussing the stock's significant volatility, debating the potential for a gamma squeeze, and weighing upcoming regulatory catalysts against the company's long-term commercialization roadmap.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing heightened investor interest as the stock gains momentum alongside broader real estate sector optimism, driven by positive pending home sales data and speculation regarding potential interest rate shifts. The community is actively debating the stock's turnaround potential, with long-term investors tracking management's strategic pivot while traders closely watch technical support levels and high options volume ahead of upcoming earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Medical Stocks Worth Watching - April 24th

Eli Lilly and Company, UnitedHealth Group, HCA Healthcare, Hims & Hers Health, Predictive Oncology, Thermo Fisher Scientific, and Novo Nordisk A/S are the seven Medical stocks to watch today...

Pharmaceutical Stocks To Follow Today - April 24th

Eli Lilly and Company, Novo Nordisk A/S, Pfizer, AbbVie, and Abbott Laboratories are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical...

Novo Nordisk A/S (NYSE:NVO) Trading Up 5.9%  - Still a Buy?

Novo Nordisk A/S (NYSE:NVO) Trading 5.9% Higher - Should You Buy...

Novo Nordisk Shares Rise After Positive Oral Semaglutide Trial In Children

Novo Nordisk shares are up on Friday after reporting oral semaglutide trial results in children aged 10-17 years old with type 2 diabetes.read more...

Incyte Gears Up to Report Q1 Earnings: What Can Investors Expect?

INCY heads into Q1 earnings with a $1.23 billion revenue view, driven by Jakafi, Opzelura, rising royalties and multiple new launches contributing to revenues.

OLD National Bancorp IN Buys 38,631 Shares of Novo Nordisk A/S $NVO

OLD National Bancorp IN raised its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 317.8% during the 4th quarter, according to the company in its most recent 13F filing with the...

<ul class="summary-bullets"><li>The brokerage believes Hims &amp; Hers' recent partnership with Novo Nordisk “could mark a turning point,” easing key legal concerns.</li><li>JPMorgan sees positives in steadier GLP-1 business, progress toward peptide legalization, revenue rebound in the second half, and the potential for additional branded partnerships.</li><li>Hims &amp; Hers expanded its GLP-1 offerings on its platform to include Eli Lilly drugs, including Zepbound, Mounjaro, and Foundayo.</li></ul>Shares of Hims &amp; Hers Health (HIMS) rose about 4% in pre-market trading on Friday after a bullish brokerage note highlighted the company’s recent partnership with Novo Nordisk, boosting optimism around its expanding GLP-1 weight-loss offerings amid intensifying competition in the space.<a href="https://stocktwits.com/symbol/HIMS">HIMS shares</a> closed lower for a third consecutive session on Thursday, declining more than 9% during the sell-off.<h2 class="st-heading-2">HIMS-NOVO Partnership Removes Key Legal Overhang</h2>JPMorgan initiated coverage of Hims &amp; Hers with an ‘Overweight’ rating and a price target of $35, according to The Fly. This represents a near 25% upside from the stock’s closing price on Thursday.Analyst Cory Carpenter believes Hims &amp; Hers recent partnership with Novo Nordisk “could mark a turning point,” easing key legal concerns and positioning the company as a broader platform spanning branded, generic, and compounded offerings.In March, Novo Nordisk <a href="https://stocktwits.com/news-articles/markets/equity/hims-platform-novo-wegovy-availability-stock-focus/cZ3sTJFRIkI">teamed</a> up with Hims &amp; Hers, allowing the telehealth platform to offer FDA-approved versions of Wegovy and Ozempic at more affordable self-pay prices, while discontinuing the promotion of compounded GLP-1 drugs.This came after Novo sued Hims &amp; Hers for patent infringement after HIMS launched a $49-per-month compounded version of Wegovy, claiming it used the same active ingredient as the branded drug.<h2 class="st-heading-2">Analyst Sees Compelling Path For Upside</h2>The brokerage noted that the company has built a leading direct-to-consumer healthcare platform, serving around 2.5 million subscribers across areas such as weight loss, women’s health, erectile dysfunction, hair loss, testosterone, and an expanding presence in international markets.Carpenter stated that a steadier GLP-1 business, progress toward peptide legalization, an expected revenue rebound in the second half, and the potential for additional branded partnerships together create a “compelling catalyst path” for upside.Hims &amp; Hers also <a href="https://stocktwits.com/news-articles/markets/equity/hims-stock-lilly-zepbound-mounjaro-foundayo-novo-ceo-netflix-early-days/cZBfUtmReRh">expanded</a> its GLP-1 offerings on its platform to include Eli Lilly drugs such as Zepbound, Mounjaro, and Foundayo.However, HIMS is facing intensifying competition after Amazon expanded its GLP-1 management program through its One Medical platform, while rival telehealth platform Ro introduced major price cuts to its weight-loss membership program.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits turned ‘bullish’ from ‘extremely bullish’ a day earlier, while message volumes remained ‘extremely high.’One user said HIMS’ chart is intact and the stock could climb to “at least” $40.<stembedurl>https://stocktwits.com/Biofocuses/message/651242376</stembedurl>Another user noted that the short float is still high.<stembedurl>https://stocktwits.com/Hognose/message/651248357</stembedurl>The stock has shed around 17% so far in 2026.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-is-ogn-stock-rising-in-pre-market-today/cZBWU3fReTp">Why Is OGN Stock Rising In Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of Hims & Hers Health Inc. (NYSE: HIMS). (Photo illustration by Cheng Xin/Getty Images)

HIMS Stock Gets Pre-Market Boost – JPMorgan Initiation Flags ‘Turning Point’ With Novo Nordisk

JPMorgan initiated coverage of Hims & Hers with an ‘Overweight’ rating and a price target of $35, according to The Fly.

After A Rough Week, HIMS May Have Found Its Catalyst – JPMorgan Sees ‘Compelling Path

Equity

Novo Nordisk (NVO) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the most recent trading session, Novo Nordisk (NVO) closed at $38.52, indicating a -1.61% shift from the previous trading day.

Hims stock price reacts strongly to crucial FDA review

Hims & Hers (HIMS) has caught a powerful new tailwind, and the market is treating peptides as more than a short-lived headline. The immediate catalyst was the FDA's decision to hold a July 23-24...

Altimmune Catalysts: 2026 Data Readouts and Financing Risks

ALT's 2026 hinges on pemvidutide, with key readouts, a phase III start, and funding strategy set to shape investor sentiment.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Current Price	$40.92
Prev Close	$38.52
Open	$40.07
Dividend Yield	2.53%
50-Day Moving Average	$39.53
Beta	0.91
Avg. Volume	19.26M
PE Ratio	11.09

52-Week High	$81.44
52-Week Low	$35.12
Market Capitalization	$129.78B
EPS (Annual)	$3.49
Price to Book	5.61
Revenue Per Employee	$679,358.45

NVO
Novo Nordisk A/S

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NVO News

NVONovo Nordisk A/S